Inactivation of recombinant human steroid sulfatase by KW-2581

Journal of Steroid Biochemistry and Molecular Biology

Volumn 108, Issue 1-2, 2008, Pages 17-22

  Ishida, Hiroyuki ^a   Sato, Natsuko ^a   Hosogi, Jun ^a   Tanaka, Hideyuki ^a   Kuwabara, Takashi ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Inhibitor; Steroid sulfatase

Indexed keywords

ESTRONE SULFATE; KW 2581; PRASTERONE SULFATE; STERYL SULFATASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CATALYSIS; ENZYME INACTIVATION; ENZYME KINETICS; ENZYME SUBSTRATE; HYDROLYSIS; IC 50; PROSTATE CANCER;

COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENZYME ACTIVATION; ESTRADIOL; HUMANS; KINETICS; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS; STERYL-SULFATASE; SULFATES; SULFONAMIDES;

EID: 38649119097     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.06.003     Document Type: Article

References (28)

1. Parenti G., Meroni G., and Ballabio A. The sulfatase gene family. Curr. Opin. Genet. Dev. 7 (1997) 386-391
2. Urbitsch P., Salzer M.J., Hirschmann P., and Vogt P.H. Arylsulfatase D gene in Xp22.3 encodes two protein isoforms. DNA Cell Biol. 19 (2000) 765-773
3. Ferrante P., Messali S., Meroni G., and Ballabio A. Molecular and biochemical characterisation of a novel sulphatase gene: Arylsulfatase G (ARSG). Eur. J. Hum. Genet. 10 (2002) 813-818
4. Conary J., Nauerth A., Burns G., Hasilik A., and von Figura K. Steroid sulfatase. Biosynthesis and processing in normal and mutant fibroblasts. Eur. J. Biochem. 158 (1986) 71-76
5. Stein C., Hille A., Seidel J., Rijnbout S., Waheed A., Schmidt B., Geuze H., and von Figura K. Cloning and expression of human steroid-sulfatase. J. Biol. Chem. 264 (1989) 13865-13872
6. Hernandez-Guzman F.G., Higashiyama T., Osawa Y., and Ghosh D. Purification, characterization and crystallization of human placental estrone/dehydroepiandrosterone sulfatase, a membrane-bound enzyme of the endoplasmic reticulum. J. Steroid Biochem. Mol. Biol. 78 (2001) 441-450
7. Hernandez-Guzman F.G., Higashiyama T., Pangborn W., Osawa Y., and Ghosh D. Structure of human estrone sulfatase suggests functional roles of membrane association. J. Biol. Chem. 278 June (2003) 22989-22997
8. Lukatela G., Krauss N., Theis K., Selmer T., Gieselmann V., von Figura K., and Saenger W. Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 37 (1998) 3654-3664
9. Bond C.S., Clements P.R., Ashby S.J., Collyer C.A., Harrop S.J., Hopwood J.J., and Guss J.M. Structure of a human lysosomal sulfatase. Structure 5 (1997) 277-289
10. Schmidt B., Selmer T., Ingendoh A., and von Figura K. A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 82 (1995) 271-278
11. Dierks T., Schmidt B., and von Figura K. Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 11963-11968
12. Recksiek M., Selmer T., Dierks T., Schmidt B., and von Figura K. Sulfatases, trapping of the sulfated enzyme intermediate by substituting the active site formylglycine. J. Biol. Chem. 273 (1998) 6096-6103
13. Knaust A., Schmidt B., Dierks T., von Bulow R., and von Figura K. Residues critical for formylglycine formation and/or catalytic activity of arylsulfatase A. Biochemistry 37 (1998) 13941-13946
14. Purohit A., Williams G.J., Howarth N.M., Potter B.V., and Reed M.J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 34 (1995) 11508-11514
15. Woo L.L., Purohit A., Malini B., Reed M.J., and Potter B.V. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Chem. Biol. 7 (2000) 773-791
16. Pasqualini J.R., and Chetrite G.S. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J. Steroid Biochem. Mol. Biol. 93 (2005) 221-236
17. Li P.K., Chu G.H., Guo J.P., Peters A., and Selcer K.W. Development of potent non-estrogenic estrone sulfatase inhibitors. Steroids 63 (1998) 425-432
18. Ishida H., Nakata T., Sato N., Li P.K., Kuwabara T., and Akinaga S. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo. Breast Cancer Res. Treat. 104 (2007) 211-219
19. Nussbaumer P., and Billich A. Steroid sulfatase inhibitors. Med. Res. Rev. 24 (2004) 529-576
20. Howarth N.M., Purohit A., Reed M.J., and Potter B.V. Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem. 37 (1994) 219-221
21. Elger W., Schwarz S., Hedden A., Reddersen G., and Schneider B. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J. Steroid Biochem. Mol. Biol. 55 (1995) 395-403
22. Purohit A., Vernon K.A., Hummelinck A.E., Woo L.W., Hejaz H.A., Potter B.V., and Reed M.J. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. J. Steroid Biochem. Mol. Biol. 64 (1998) 269-275
23. Fischer D.S., Woo L.W., Mahon M.F., Purohit A., Reed M.J., and Potter B.V. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase. Bioorg. Med. Chem. 11 (2003) 1685-1700
24. Purohit A., Hejaz H.A., Woo L.W., van Strien A.E., Potter B.V., and Reed M.J. Recent advances in the development of steroid sulphatase inhibitors. J. Steroid Biochem. Mol. Biol. 69 (1999) 227-238
25. Malini B., Purohit A., Ganeshapillai D., Woo L.W., Potter B.V., and Reed M.J. Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates. J. Steroid Biochem. Mol. Biol. 75 (2000) 253-258
26. Stanway S.J., Purohit A., Woo L.W., Sufi S., Vigushin D., Ward R., Wilson R.H., Stanczyk F.Z., Dobbs N., Kulinskaya E., Elliott M., Potter B.V., Reed M.J., and Coombes R.C. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor. Clin. Cancer Res. 12 (2006) 1585-1592
27. Nussbaumer P., Lehr P., and Billich A. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase. J. Med. Chem. 45 (2002) 4310-4320
28. Woo L.W., Lightowler M., Purohit A., Reed M.J., and Potter B.V. Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism. J. Steroid Biochem. Mol. Biol. 57 (1996) 79-88